Delivery Order SPE2DB22D1202-SPE2DB25FURY1

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,313.70, is a Firm Fixed Price Delivery Order to supply the government with FOSAMAX 70 MG TABLET medication. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The award, valued at $4,008.21, is for the delivery of Fosamax 70 MG Tablet pharmaceutical products to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order that runs through January 14, 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999...
This federal contract award, valued at $4,594.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FOSAMAX 70 MG TABLET UU 4S, a pharmaceutical product. This is a firm-fixed-price delivery order contract with a completion date of January 29, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a leading pharmaceutical distribution company, to provide Fosamax 70 mg tablets. The firm fixed price delivery order has a ceiling value of $1,362.82 and a completion date of March 22, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $2,844.39, is a firm fixed price delivery order for the supply of FOSAMAX 70 MG TABLET UU 4S. No set-aside designation was used for this contract. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,284.25 Firm Fixed Price Delivery Order contract covers the supply of FOSAMAX 70 MG Tablets to support military healthcare programs. The contract has an ultimate completion date of February 5, 2025 and was awarded on February 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, valued at $1,282.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564491503 FOSAMAX 70 MG tablets, a medication used for the treatment of osteoporosis. The award has an ultimate completion date of May 6, 2024 and is a Firm Fixed Price Delivery Order contract. This contract is not designated as a set-aside. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,002.10 firm fixed-price delivery order is for the supply of FOSAMAX 70 MG TABLET UU 4S, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Fosamax 70 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $7,170.74, and has an ultimate completion date of April 23, 2024. Amerisourcebergen, through its Corporate Office division, is the prime contractor on this award. The company holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,180.13 firm fixed-price delivery order is for the supply of Fosamax 70 mg tablets, which are likely used in the treatment of osteoporosis. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant $999,999,999 Indefinite...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FURY1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,400.98 firm fixed-price delivery order contract is for the supply of FOSAMAX 70 MG TABLET UU 4S, a medical product. The contract has an ultimate completion date of February 6, 2025.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for federal beneficiaries. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 5/7/25, 9:59 AM